Kura Oncology Announces Acceptance of Two Abstracts for Presentation
– Presentations highlighting preclinical data supporting the combination of FTIs with KRASG12C Inhibitors and Tyrosine Kinase Inhibitors – SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE)